Trial Profile
A 15 year safety surveillance study monitoring possible association between teriparatide treatment and osteosarcoma.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Aug 2021
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Male osteoporosis; Osteoporosis; Postmenopausal osteoporosis
- Focus Adverse reactions
- 30 Aug 2017 Interim results (n=1031) presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management
- 07 Nov 2016 New trial record